Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

October 15, 2014

Conditions
Esophageal Cancer
Interventions
DRUG

cisplatin

Given IV

DRUG

irinotecan hydrochloride

Given IV

PROCEDURE

therapeutic conventional surgery

Undergo Surgery

RADIATION

radiation therapy

Undergo radiation

Trial Locations (24)

10065

Memorial Sloan-Kettering Cancer Center, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

14215

Veterans Affairs Medical Center - Buffalo, Buffalo

27534

Wayne Memorial Hospital, Incorporated, Goldsboro

46350

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

Michiana Hematology-Oncology, PC - South Bend, South Bend

46904

Howard Community Hospital, Kokomo

49085

Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph

68114

Methodist Estabrook Cancer Center, Omaha

46545-1470

Saint Joseph Regional Medical Center, Mishawaka

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

04401

CancerCare of Maine at Eastern Maine Medical Center, Bangor

04074

Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough

03301

New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord

03106

New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett

03246

Lakes Region General Hospital, Laconia

03103

Elliot Regional Cancer Center at Elliot Hospital, Manchester

14263-0001

Roswell Park Cancer Institute, Buffalo

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

05602

Mountainview Medical, Berlin Corners

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00316862 - Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | Biotech Hunter | Biotech Hunter